Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Descotes

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Breast Cancer Research : BCR|October 27, 2012
High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patientsNicolas Pernodet, François Hermetet, Pascale Adami, et al.
The American Journal of Surgical Pathology|September 10, 2020
Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell TumorsPauline Baillard, Catherine Genestie, Sabrina Croce, et al.
Diagnostic Cytopathology|October 26, 2021
Feasibility and performance of the Idylla™ NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspirationMaud Hamadou, Jonathan Lopez, Nazim Benzerdjeb, et al.
Histopathology|March 28, 2026
Validating the 2022 WHO classification in thyroid carcinomas: Prospective evidence for predicting iodine resistanceElise André, Laurine Mebarki, Mirela Ilie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2025
The MEF2D::NCOA2 Fusion Defines a Distinct Emerging Vulvovaginal Myxoid Epithelioid Tumor With Smooth Muscle DifferentiationAlexis Trecourt, Guillaume Bataillon, François Le Loarer, et al.
Pediatric Blood & Cancer|May 18, 2021
NTRK2 gene fusion and resistance mutation: Seventeen-year course of a paediatric gliomaMarc Barritault, Delphine Poncet, David Meyronet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinomaClaire Bournaud, Françoise Descotes, Myriam Decaussin-Petrucci, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic TumorsGaspard Jeremie, Fabienne Allias, Alexis Trecourt, et al.
Histopathology|December 9, 2024
Understanding and overcoming the pitfalls in the diagnosis of pleomorphic and carcinoma ex-pleomorphic adenoma of salivary glandsZiyad Alsugair, Charles Lépine, Maxime Fieux, et al.
World Journal of Urology|January 2, 2023
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic reviewYanish Soorojebally, Yann Neuzillet, Mathieu Roumiguié, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Breast Cancer Research : BCR|October 27, 2012
High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patientsNicolas Pernodet, François Hermetet, Pascale Adami, et al.
The American Journal of Surgical Pathology|September 10, 2020
Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell TumorsPauline Baillard, Catherine Genestie, Sabrina Croce, et al.
Diagnostic Cytopathology|October 26, 2021
Feasibility and performance of the Idylla™ NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspirationMaud Hamadou, Jonathan Lopez, Nazim Benzerdjeb, et al.
Histopathology|March 28, 2026
Validating the 2022 WHO classification in thyroid carcinomas: Prospective evidence for predicting iodine resistanceElise André, Laurine Mebarki, Mirela Ilie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2025
The MEF2D::NCOA2 Fusion Defines a Distinct Emerging Vulvovaginal Myxoid Epithelioid Tumor With Smooth Muscle DifferentiationAlexis Trecourt, Guillaume Bataillon, François Le Loarer, et al.
Pediatric Blood & Cancer|May 18, 2021
NTRK2 gene fusion and resistance mutation: Seventeen-year course of a paediatric gliomaMarc Barritault, Delphine Poncet, David Meyronet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinomaClaire Bournaud, Françoise Descotes, Myriam Decaussin-Petrucci, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic TumorsGaspard Jeremie, Fabienne Allias, Alexis Trecourt, et al.
Histopathology|December 9, 2024
Understanding and overcoming the pitfalls in the diagnosis of pleomorphic and carcinoma ex-pleomorphic adenoma of salivary glandsZiyad Alsugair, Charles Lépine, Maxime Fieux, et al.
World Journal of Urology|January 2, 2023
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic reviewYanish Soorojebally, Yann Neuzillet, Mathieu Roumiguié, et al.
Pageof 6